TY  - BOOK
AU  - Becker,Richard C.
AU  - Spencer,Fredrick A.
TI  - Antithrombotic therapy in the prevention of ischemic stroke
T2  - Oxford American pocket notes
SN  - 9780199774449
AV  - RC388.5 .B43 2010eb
U1  - 616.81061 22
PY  - 2010///
CY  - Oxford, New York
PB  - Oxford University Press
KW  - Transient ischemic attack
KW  - Chemotherapy
KW  - Prevention
KW  - Fibrinolytic agents
KW  - Ischemic Attack, Transient
KW  - drug therapy
KW  - prevention & control
KW  - Fibrinolytic Agents
KW  - Accident ischémique transitoire
KW  - Chimiothérapie
KW  - Fibrinolytiques
KW  - HEALTH & FITNESS
KW  - Diseases
KW  - General
KW  - bisacsh
KW  - MEDICAL
KW  - Clinical Medicine
KW  - Evidence-Based Medicine
KW  - Internal Medicine
KW  - fast
KW  - Electronic books
N1  - Includes bibliographical references; Cover; Contents; Introduction and Epidemiology; Pathophysiology; Regulatory Factors in Thrombus Formation; Cellular Interactions in Atherothrombosis; Classification of Stroke; Managing Risk Factors for Recurrent Stroke; Antithrombotic Therapy for Prevention of Recurrent TIA and Stroke; Aspirin; Mechanism of Action; Pharmacokinetics; Adverse Effects; Aspirin Administration in Clinical Practice; Secondary Prevention of Vascular Events and Stroke; Aspirin Dosing in Prevention of Recurrent TIA/Stroke; Thienopyridines (Clopidogrel, Ticlopidine, and Prasugrel); Mechanism of Action; Clopidogrel; PharmacokineticsAbsorption; Adverse Effects; Prevention of Vascular Events; Ticlopidine; Prasugrel; Dipyridamole, Extended-Release Dipyridamole/Aspirin Combination (Aggrenox); Mechanism of Action; Pharmacokinetics; Pharmacodynamics; Adverse Effects; Administration in Older Patients; Clinical Experience; Cilostazol; References
N2  - Stroke is the most common cause of adult mortality in the United States. Antithrombotic agents form the mainstay of stroke prevention. Aspirin produces a modest reduction in the risk of second stroke and transient ischemic attack (TIA, mini-stroke) and is widely recommended for initial therapy. The thienopyridines (Ticlid) and clopodogrel (Plavix) are alternatives for secondary prevention in patients who do not respond to or cannot take aspirin. They are no more effective than aspirin and have been associated with thrombotic thrombocytopenic purpura. The combination of aspirin and extended-rel
UR  - https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=669957
ER  -